WHAT IS KNOWN ON THE SUBJECT?: The experiences of transgender people are becoming increasingly more visible in popular culture, biographical literature and the media. The topic has received little attention within the psychiatric and mental health nursing literature. There is a paucity of literature exploring the impact on relationships following a disclosure of transgenderism. WHAT DOES THIS PAPER ADD TO EXISTING KNOWLEDGE?: A narrative account of the consequences for the wife of one transwoman and their relationships with friends and family following the disclosure of transgenderism. The article identifies a range of issues that require further attention in relation to healthcare provision. These include the mental health needs of partners and spouses; attitudes of healthcare professionals towards transgender issues; and the adequacy of the formal support offered to partners and spouses of transgender people. WHAT ARE THE IMPLICATIONS FOR PRACTICE?: There is a need for healthcare practitioners to explore their understanding of transgender issues and how these may impact on the mental health of partners and spouses. It is important that healthcare professionals provide a hopeful and supportive environment to enable couples to explore their relationships following disclosure of transgenderism.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/jpm.12371 | DOI Listing |
Obstet Gynecol Clin North Am
December 2024
Boston HAPPENS Program, Division of Adolescent/Young Adult Medicine, Department of Pediatrics, Boston Children's Hospital, 333 Longwood Avenue, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA.
Transgender and gender nonbinary (TGNB) patients may seek out gynecologic care for a variety of reasons. It is important for gynecologic providers to possess a comprehensive understanding and comfort level in caring for TGNB adolescents and young adults. This piece discusses the gynecologic care of TGNB adolescents and young adults.
View Article and Find Full Text PDFEndocr Pract
January 2025
Division of Endocrinology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York; Center for Transgender Medicine and Surgery, Mount Sinai Health System, New York, New York.
Introduction: Individuals may seek gender-affirming hormone therapy (GAHT) to align their physical appearance with their gender identity. Feminizing GAHT typically involves the use of estrogen. This study investigates the effect of route of administration (ROA) and dose of estradiol on estradiol (E2) and testosterone (T) levels in transfeminine individuals.
View Article and Find Full Text PDFEndocr Pract
December 2024
Department of Medicine, Division of Endocrinology, Metabolism and Lipids, Emory University School of Medicine, Atlanta, Georgia; Atlanta VA Medical Center, Decatur, Georgia.
Obstet Gynecol Clin North Am
June 2024
Department of Surgery, Section of Plastic and Reconstructive Surgery, The University of Chicago, 5841 South Maryland Avenue, Chicago, IL 60637, USA.
Pediatrics
May 2024
Division of Endocrinology, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts.
Objectives: Guidelines for monitoring of medications frequently used in the gender-affirming care of transgender and gender-diverse (TGD) adolescents are based on studies in adults or other medical conditions. In this study, we aimed to investigate commonly screened laboratory measurements in TGD adolescents receiving gender-affirming hormone therapy (GAHT).
Methods: TGD adolescents were recruited from 4 study sites in the United States before beginning GAHT.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!